Multi-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence Prediction
NCT06638762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1325
Last updated 2024-10-15
Summary
Background:
Head and neck squamous cell carcinoma is one of the most common cancers. Postoperative recurrence is a risk factor for poor prognosis and decreased survival rate. There is a lag and passivity in the diagnosis and monitoring of postoperative recurrence in clinical diagnosis and treatment. The application of artificial intelligence to explore and develop a model for predicting postoperative recurrence of oral squamous cell carcinoma is expected to solve clinical difficulties and guide the formulation of postoperative monitoring and diagnosis and treatment plans.
Materials and Methods: We recruited patients diagnosed with oral squamous cell carcinoma who had received surgical treatment, collected patient follow-up information and postoperative pathological images, enhanced and standardized pathological images, and extracted pathological features through visual transformation model (ViT). The features of pathological images were fused into a multi-layer perceptron model (MLP) for training, verification and testing, and the predictive performance of the model was evaluated by various indexes.
Results:
Among the 1325 patients enrolled, 275 relapsed, accounting for 20.8%. The optimized ViT-Small model has a validation AUC of 94.79% (90% accuracy) and a test AUC of 95.68% (91.5% accuracy), and outperforms other models on both validation and test sets.
Conclusion:
ViT-Small model have high predictive performance, which is expected to predict postoperative recurrence, guide the formulation of clinical diagnosis and treatment plan.
Conditions
- Cancer of Head and Neck
Interventions
- PROCEDURE
-
surgery
We recruited patients diagnosed with oral squamous cell carcinoma who had received surgical treatment, collected patient follow-up information and postoperative pathological images, enhanced and standardized pathological images, and extracted pathological features through visual transformation model.
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-01
- Primary Completion
- 2022-12-31
- Completion
- 2024-09-01
More Related Trials
-
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT06035250 ·Status: RECRUITING
-
Prospective, Observational, Real-world Oral Malignant Tumors Study
NCT02395367 ·Status: COMPLETED
-
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
NCT06451393 ·Status: RECRUITING
-
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052 ·Status: NOT_YET_RECRUITING
-
the Re-irradiation of Recurrent Cervical Cancer by IMRT
NCT03170570 ·Status: UNKNOWN ·Phase: NA
-
Using Artificial Intelligence to Predict Rectal Cancer Outcomes
NCT05723965 ·Status: COMPLETED
-
Recurrence and Prognosis Prediction Model for Gastric Cancer
NCT07243847 ·Status: COMPLETED
-
Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study
NCT06897306 ·Status: COMPLETED
-
Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer
NCT06314750 ·Status: COMPLETED
-
Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
NCT06717763 ·Status: COMPLETED
-
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
NCT06739252 ·Status: TERMINATED ·Phase: PHASE2
-
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 ·Status: RECRUITING ·Phase: PHASE2
-
Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM
NCT06208371 ·Status: RECRUITING ·Phase: PHASE3
-
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
NCT05354674 ·Status: NOT_YET_RECRUITING
-
Tomotherapy in Postsurgery Recurrent Carcinoma Cervix
NCT01117402 ·Status: UNKNOWN ·Phase: PHASE2
-
Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era
NCT03138642 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
NCT04895137 ·Status: COMPLETED ·Phase: PHASE2
-
CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC
NCT06609070 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
NCT00232960 ·Status: UNKNOWN ·Phase: NA
-
RT for Cervical Adenocarcinoma/adenosquamous Carcinoma
NCT06741046 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
NCT06931873 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
NCT06440044 ·Status: COMPLETED
-
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
NCT06781151 ·Status: RECRUITING
-
Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer
NCT00822562 ·Status: COMPLETED ·Phase: NA